Laboratories Co., Ltd. is a listed company established in the year 1971. The manufacture and distribution of conventional medicine. Office and Factory are located at No.47 Soi Boonchana, Sukhumvit 59, Klong Ton
Sustainability Investment n/a Ranking by Industry Business 4/ Business Research & development and distribution of healthcare products and aesthetic innovation products for human including health products for pets
baht, 3.2% growth y-y. As of February 28, 2023, the Company had total cards and distribution networks as below; Number of AEONTS Cards and Networks February 28, 2022 February 28, 2023 Number of Credit
Bt309mn (see significant event). As a result, net profit was Bt7,469mn, +14% YoY and +3.5% QoQ. Significant Events 1. On 2 nd October 2017, AIS submitted an intention to acquire the entire stake, upon
-113.3% Financial expenses -0.66 -1.16 0.50 -43.1% Share of income from investment in associate 0.09 0.52 -0.43 -82.7% Income tax expenses 0.82 -6.58 7.40 -112.5% Net profit for the period -4.40 27.71
financial statement with FKRMM, NDR’s profit will implicitly increase because since the year 2014 to 2016, FKRMM has continued operating profit of 66.23, 61.12 and 54.58 million baht respectively (refer to
security N/A 2 Net Operating Profit Criteria Cannot be calculated since disposed asset is not security N/A 3 Total Value of Consideration Criteria Total value of consideration x 100 / Total asset of the
distribution by using the proceeds from perpetual license of Japan market format as consideration for investment. DDInter intends to sell shares in the amount of 50% to Welcome Co., Ltd. which is not a connected
to slower sales in institutional sector and domestic market while export sales grew by 0.2% by strengthening distribution channels in countries beyond core markets. The Company reported gain from
1,494 8% EBITDA Bio-Based Product Business4/ 113 179 59 -48% -67% 259 238 -8% EBITDA Resource Business5/ 59 133 93 58% -30% 81 226 181% EBITDA Others 6/ (25) (25) (12) 54% 53% (25) (37) -48% Profit